What does LMDB RHUMATOLOGIE do?

LMDB RHUMATOLOGIE is an events organiser in Tervuren. Private Limited, started on 26 July 2011, 1 establishment.

What is the address of LMDB RHUMATOLOGIE?

The registered office of LMDB RHUMATOLOGIE is located at Katangabinnenhof 8, 3080 Tervuren.

Is LMDB RHUMATOLOGIE still active?

Yes. According to the CBE (30 October 2026) LMDB RHUMATOLOGIE is active, legal situation “Normale toestand”, started on 26 July 2011.

Is LMDB RHUMATOLOGIE registered on Peppol?

Yes, LMDB RHUMATOLOGIE is registered on the Peppol network with ID 0208:0838114543.

What is the enterprise number of LMDB RHUMATOLOGIE?

The enterprise number of LMDB RHUMATOLOGIE is BE0838114543.

When was LMDB RHUMATOLOGIE founded?

LMDB RHUMATOLOGIE was founded on 26 July 2011.

Who are the directors of LMDB RHUMATOLOGIE?

According to the 2025 annual accounts, the directors of LMDB RHUMATOLOGIE are: Laurent Meric de Bellefon.

Is LMDB RHUMATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 July 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LMDB RHUMATOLOGIE make in 2025?

LMDB RHUMATOLOGIE posted a profit after taxes of € 41,856 in financial year 2025.

What is the revenue of LMDB RHUMATOLOGIE?

As a small company, LMDB RHUMATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 93,843.

Does LMDB RHUMATOLOGIE have a website?

Yes, LMDB RHUMATOLOGIE has a website at debellefon.be.

LMDB RHUMATOLOGIE (Private Limited) - Tervuren

Dossier LMDB RHUMATOLOGIE, printed on 30 October 2026 from databakkes.be/en/0838114543/lmdb-rhumatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LMDB RHUMATOLOGIE from Tervuren, company number BE0838114543, closed financial year 2025 with a result of € 41,856 after tax. For that financial year LMDB RHUMATOLOGIE recorded a gross margin of € 93,843 and equity of € 200,105. Compared with financial year 2024, the result moved from € 54,659 to € 41,856. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.

What it is worth Growing

€ 200,105

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 41,856

▼ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 80,752

▲ 229% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 8,803 paid out

21 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 37,732

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 58,345

▼ 20% vs 2024

€ 15,488 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 6,889

▲ 136% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,186

▼ 23% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 47,447 Gross margin 2022: € 47,447 First fiscal year in the series	€ 93,015 Gross margin 2023: € 93,015 ▲ 96% vs 2022 (€ 47,447) Favourable step	€ 108,685 Gross margin 2024: € 108,685 ▲ 17% vs 2023 (€ 93,015) Favourable step	€ 93,843 Gross margin 2025: € 93,843 ▼ 14% vs 2024 (€ 108,685) Unfavourable step	▼ 14%
Profit after taxes	€ 25,496 Profit after taxes 2022: € 25,496 First fiscal year in the series	€ 50,085 Profit after taxes 2023: € 50,085 ▲ 96% vs 2022 (€ 25,496) Favourable step	€ 54,659 Profit after taxes 2024: € 54,659 ▲ 9% vs 2023 (€ 50,085) Favourable step	€ 41,856 Profit after taxes 2025: € 41,856 ▼ 23% vs 2024 (€ 54,659) Unfavourable step	▼ 23%
Equity	€ 81,367 Equity 2022: € 81,367 First fiscal year in the series	€ 117,468 Equity 2023: € 117,468 ▲ 44% vs 2022 (€ 81,367) Favourable step	€ 167,052 Equity 2024: € 167,052 ▲ 42% vs 2023 (€ 117,468) Favourable step	€ 200,105 Equity 2025: € 200,105 ▲ 20% vs 2024 (€ 167,052) Favourable step	▲ 20%
Total debts	€ 55,319 Total debts 2022: € 55,319 First fiscal year in the series	€ 136,204 Total debts 2023: € 136,204 ▲ 146% vs 2022 (€ 55,319) Unfavourable step	€ 91,368 Total debts 2024: € 91,368 ▼ 33% vs 2023 (€ 136,204) Favourable step	€ 95,157 Total debts 2025: € 95,157 ▲ 4% vs 2024 (€ 91,368) Unfavourable step	▲ 4%
Cash	€ 73,722 Cash 2022: € 73,722 First fiscal year in the series	€ 88,008 Cash 2023: € 88,008 ▲ 19% vs 2022 (€ 73,722) Favourable step	€ 24,510 Cash 2024: € 24,510 ▼ 72% vs 2023 (€ 88,008) Unfavourable step	€ 80,752 Cash 2025: € 80,752 ▲ 229% vs 2024 (€ 24,510) Favourable step	▲ 229%
Land & buildings	€ 5,942 Land & buildings 2022: € 5,942 First fiscal year in the series	€ 5,345 Land & buildings 2023: € 5,345 ▼ 10% vs 2022 (€ 5,942) Unchanged	€ 4,748 Land & buildings 2024: € 4,748 ▼ 11% vs 2023 (€ 5,345) Unchanged	€ 4,151 Land & buildings 2025: € 4,151 ▼ 13% vs 2024 (€ 4,748) Unchanged	▼ 13%
Retained profit	€ 68,967 Retained profit 2022: € 68,967 First fiscal year in the series	€ 105,068 Retained profit 2023: € 105,068 ▲ 52% vs 2022 (€ 68,967) Favourable step	€ 154,652 Retained profit 2024: € 154,652 ▲ 47% vs 2023 (€ 105,068) Favourable step	€ 187,705 Retained profit 2025: € 187,705 ▲ 21% vs 2024 (€ 154,652) Favourable step	▲ 21%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 13,985 Dividend 2023: € 13,985 Unchanged (€ 0) Unchanged	€ 5,075 Dividend 2024: € 5,075 ▼ 64% vs 2023 (€ 13,985) Unchanged	€ 8,803 Dividend 2025: € 8,803 ▲ 73% vs 2024 (€ 5,075) Unchanged	▲ 73%
Bank debt	€ 21,562 Bank debt 2022: € 21,562 First fiscal year in the series	€ 87,952 Bank debt 2023: € 87,952 ▲ € 66,390 vs 2022 (€ 21,562) Unfavourable step	€ 73,371 Bank debt 2024: € 73,371 ▼ 17% vs 2023 (€ 87,952) Favourable step	€ 58,345 Bank debt 2025: € 58,345 ▼ 20% vs 2024 (€ 73,371) Favourable step	▼ 20%
Balance sheet total	€ 136,686 Balance sheet total 2022: € 136,686 First fiscal year in the series	€ 253,671 Balance sheet total 2023: € 253,671 ▲ 86% vs 2022 (€ 136,686) Unchanged	€ 258,419 Balance sheet total 2024: € 258,419 ▲ 2% vs 2023 (€ 253,671) Unchanged	€ 295,262 Balance sheet total 2025: € 295,262 ▲ 14% vs 2024 (€ 258,419) Unchanged	▲ 14%

Key figures of LMDB RHUMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LMDB RHUMATOLOGIE?

What happened at LMDB RHUMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 5, 2026 New annual accounts for financial year 2025: profit of € 41,856 (▼ 23% vs 2024). Source: NBB ↗
2023 Laurent Meric de Bellefon became a director. NBB
Jul 26, 2011 Start of the company according to the CBE. KBO
Jul 25, 2011 New establishment in Tervuren. KBO

In short

From € 25,496 profit in 2022 to € 41,856 profit in 2025.

Paid € 73,488 in corporate taxes since 2022.

Best year ever: 2024, with € 54,659 profit.

Paid out € 27,863 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Laurent Meric de Bellefon

LMDB RHUMATOLOGIE

SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE

Behind LMDB RHUMATOLOGIE is Laurent Meric de Bellefon. Laurent Meric de Bellefon is also behind SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE.

Directors

According to the 2025 annual accounts

Laurent Meric de Bellefon

Director

Also active at: SOCIETE ROYALE BELGE DE RHUMATOLOGIE KONINKLIJKE BELGISCHE VERENIGING VOOR REUMATOLOGIE

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Katangabinnenhof 8

3080 Tervuren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS debellefon.be

Technologies

BootstrapDrupalNginxVarnishjQuery

Hosting & Email

Email provider

OVH Mail

Hosting

COMBELL-AS, BE

DNS

OVH DNS

Website info

HTTPS Ja

Languages NL

Features

Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number: 0838.114.543
VAT number: BE 0838.114.543
Registered office: Katangabinnenhof 8, 3080 Tervuren
Names & denominations: LMDB RHUMATOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 July 2011
Peppol: Active · Active since 9 Mar 2025
Contact: debellefon.be
Activities · NACE: Organisatie van congressen en beurzen

View on CBE Public ↗ Annual accounts (NBB) ↗